Using pCIN-mIL-4 DNA vector to express mRNA and protein and to improve herpes simplex virus-induced Behcet's disease symptoms in mice

Vaccine

Volumn 25, Issue 41, 2007, Pages 7047-7055

  Lee, Seung Ihm ^a   Kwon, Hyuk Jae ^a   Lee, Eun So ^b   Yang, Byung Chul ^c   Bang, Dongsik ^d   Lee, Sungnack ^b   Sohn, Seonghyang ^a,e  

^a Ajou University   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c Department of Genetic Engineering   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

^e Brain Korea 21 Project for Medical Science   (South Korea)

Author keywords

Behcet's disease; DNA vaccine; Herpes simplex virus; IL 4

Indexed keywords

CYTOKINE; INTERLEUKIN 4; INTERLEUKIN 4 ANTIBODY; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHCET DISEASE; CONTROLLED STUDY; DNA VECTOR; DRUG SYNTHESIS; ERYTHEMA; GENE EXPRESSION; GENE THERAPY; GENITAL SYSTEM; HERPES SIMPLEX VIRUS; IN VIVO STUDY; LYMPH NODE; MALE; MOUSE; MOUTH ULCER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; SYMPTOM; TH2 CELL; UPREGULATION;

ANIMALS; BEHCET SYNDROME; GENE THERAPY; GENETIC VECTORS; HERPES SIMPLEX; INTERLEUKIN-4; LYMPH NODES; LYMPHOCYTES; MALE; MICE; MICE, INBRED ICR; PLASMIDS; RNA, MESSENGER; SPLEEN;

EID: 34648814050     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.07.062     Document Type: Article

References (41)

1. Yazici H., and Barnes C.G. Practical treatment recommendations for pharmacotherapy of Behçet's syndrome. Drugs 42 (1991) 796-804
2. Sohn S., Lee E.S., and Lee S. The correlation of MHC haplotype and development of Behcets disease-like symptoms induced by herpes simplex virus in several inbred mouse strains. J Dermatol Sci 26 (2001) 173-181
3. Lee S., Bang D., Cho Y.H., Lee E.S., and Sohn S. Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patients with Behcet's disease. Arch Dermatol Res 288 (1996) 179-183
4. Studd M., McCance D.J., and Lehner T. Detection of HSV-1 DNA in patients with Behcet's syndrome and in patients with recurrent oral ulcers by the polymerase chain reaction. J Med Microbiol 34 (1991) 39-43
5. Tojo M., Zheng X., Yanagihori H., Oyama N., Takahashi K., Nakamura K., et al. Detection of herpes virus genomes in skin lesions from patients with Behcet's disease and other related inflammatory diseases. Acta Derm Venereol 83 (2003) 124-127
6. Hooks J.J. Possibility of a viral etiology in recurrent aphthous ulcers and Behçet's syndrome. J Oral Pathol 7 (1978) 353-364
7. Behcet H. Uber rezidivierende, aphthose durch ein Virus verursachte Geschwure am Mund, am Auge und an den Genitalen. Dermatol Wochenschr 105 (1937) 1152
8. Lee E.S., Lee S., Bang D., and Sohn S. Detection of herpes simplex virus DNA by polymerase chain reaction in genital ulcer of patients with Behcet's disease. Revue du Rhumatisme 63 (1996) 532
9. Lee E.S., Lee S., Bang D., Sohn S., Park C., and Lee K. Herpes simplex virus detection by polymerase chain reaction in intestinal ulcer of patients with Behcet's disease. J Invest Dermatol 101 (1993) 474
10. Eglin R.P., Lehner T., and Subak-Sharpe J.H. Detection of RNA complementary to herpes simplex virus in mononuclear cells from patients with Behcet's syndrome and recurrent oral ulcers. Lancet 2 (1982) 1356-1361
11. Sohn S. Etiology of Behcet's disease; Herpes simplex virus infection and animal model. Yonsei Med J 38 (1997) 359-364
12. Sohn S., Lee E.S., Bang D., and Lee S. Behcet's disease-like symptoms induced by the Herpes simplex virus in ICR mice. Eur J Dermatol 8 (1998) 21-23
13. Lee S., Bang D., Lee E.S., and Sohn S. Immunologic aspects. In: Lee S., Bang D., Lee E.S., and Sohn S. (Eds). Behcet's disease: a guide to its clinical understanding (2001), Springer, Heidelberg 19-50
14. Davies U.M., Palmer R.G., and Denman A.M. Treatment with acyclovir does not affect orogenital ulcers in Behcet's syndrome: a randomized double-blind trial. Br J Rheumatol 27 (1988) 300-302
15. Sohn S., Bang D., Lee E.S., Kwon H.J., Lee S.I., and Lee S. Experimental studies on the antiviral agent famciclovir in Behcet's disease symptoms in ICR mice. Br J Dermatol 145 (2001) 799-804
16. Yasuoka H., Okazaki Y., Kawakami Y., Hirakata M., Inoko H., Ikeda Y., et al. Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behcet's disease. Arthritis Rheum 50 (2004) 3658-3662
17. Yang P., Chen L., Zhou H., Zhong H., Wang H., Huang X., et al. Resistance of lymphocytes to Fas-mediated apoptosis in Behcet's disease and Vogt-Koyangi-Harada syndrome. Ocul Immunol Inflamm 10 (2002) 47-52
18. Sohn S., Lee E.S., Kwon H.J., Lee S.I., Bang D., and Lee S. Expression of Th2 cytokines decreases the development of and improves Behcet's disease-like symptoms induced by herpes simplex virus in mice. J Inf Dis 183 (2001) 1180-1186
19. Frassanito M.A., Dammacco R., Cafforio P., and Dammacco F. Th1 polarization of the immune response in Behcet's disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum 42 (1999) 1967-1974
20. Hirohata S., and Hashimoto T. Resistance of lymphocytes to Fas-mediated apoptosis in Behçet's disease and Vogt-Koyangi-Harada syndrome. Clin Exp Immunol 112 (1998) 317-324
21. Lee S., Bang D., Lee E.S., and Sohn S. Immunologic aspects. In: Lee S., Bang D., Lee E.S., and Sohn S. (Eds). Behcet's disease: a guide to its clinical understanding (2001), Springer, Heidelberg 59-62
22. Koarada S., Haruta Y., Tada Y., Ushiyama O., Morito F., Ohta A., et al. Increased entry of CD4+ T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behcet's disease. Rheumatology (Oxford) 43 (2004) 843-851
23. Garren H., Ruiz P.J., Watkins T.A., Fontoura P., Nguyen L.T., Estline E.R., et al. Combination of gene delivery and DNA vaccination to protect from and reverse Th1 autoimmune disease via deviation to the Th2 pathway. Immunity 15 (2001) 15-22
24. Robinson H.L., and Torres C.A. DNA vaccines. Semin Immunol 9 (1997) 271-283
25. Kumar S., Yan J., Muthumani K., Ramanathan M.P., Yoon H., Pavlakis G.N., et al. Immunogenicity testing of a novel engineered HIV-1 envelope gp140 DNA vaccine construct. DNA Cell Biol 25 (2006) 383-392
26. Lobell A., Weissert R., Eltayeb S., Svanholm C., Olsson T., and Wigzell H. Presence of CpG DNA and the local cytokine milieu determine the efficacy of suppressive DNA vaccination in experimental autoimmune encephalomyelitis. J Immunol 163 (1999) 4754-4762
27. Wildbaum G., Youssef S., and Karin N. A targeted DNA vaccine augments the natural immune response to self TNF-alpha and suppresses ongoing adjuvant arthritis. J Immunol 165 (2000) 5860-5866
28. Muthumani K., Zhang D., Dayes N.S., Hwang D.S., Calarota S.A., Choo A.Y., et al. Novel engineered HIV-1 East African Clade-A gp160 plasmid construct induces strong humoral and cell-mediated immune responses in vivo. Virology 314 (2003) 134-146
29. Lemesre J.L., Holzmuller P., Cavaleyra M., Goncalves R.B., Hottin G., and Papierok G. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes. Vaccine 23 22 (2005) 2825-2840
30. Flynn J.C., Rao P.V., Gora M., Alsharabi G., Wei W., Giraldo A.A., et al. Graves' hyperthyroidism and thyroiditis in HLA-DRB1*0301 (DR3) transgenic mice after immunization with thyrotropin receptor DNA. Clin Exp Immunol 135 1 (2004) 35-40
31. Pichurin P., Yan X.M., Farilla L., Guo J., Chazenbalk G.D., Rapoport B., et al. Naked TSH receptor DNA vaccination: A TH1 T cell response in which interferon-gamma production, rather than antibody, dominates the immune response in mice. Endocrinology 142 8 (2001) 3530-3536
32. Li L., Lee H.H., Bell J.J., Gregg R.K., Ellis J.S., Gessner A., et al. IL-4 utilizes an alternative receptor to drive apoptosis of Th1 cells and skews neonatal immunity toward Th2. Immunity 20 4 (2004) 429-440
33. So E.Y., Park H.H., and Lee C.E. IFNγ and IFN-alpha posttranscriptionally down-regulate the IL-4-induced IL-4 receptor gene expression. J Immunol 165 10 (2000) 5472-5479
34. Miyashita H., Katayama N., Fujieda A., Shibasaki T., Tamamura K., Sugimoto Y., et al. IL-4 and IL-10 synergistically inhibit survival of human blood monocytes supported by GM-CSF. Int J Oncol 26 3 (2005) 731-735
35. Hodge G., Hodge S., Reynolds P.N., and Holmes M. Increased intracellular pro- and anti-inflammatory cytokines in bronchoalveolar lavage T cells of stable lung transplant patients. Transplantation 80 8 (2005) 1040-1045
36. Ho S.-H., Hahn W., Lee H.-J., Kim D.-S., Jeong J.-G., Kim S., et al. Protection against collagen-induced arthritis by electrotransfer of an expression plasmid for the interleukin-4. Biochem Biophys Res Commun 321 (2004) 759-766
37. Lee S.W., Youn J.W., Seong B.L., and Sung Y.C. IL-6 induces long-term protective immunity against a lethal challenge of influenza virus. Vaccine 17 (1999) 490-496
38. Dranoff G., Jaffee E., Lazenby A., Golumbek P., Levitsky H., Brose K., et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90 (1993) 3539-3543
39. Lima K.M., dos Santos S.A., Santos R.R., Brandao I.T., Rodrigues Jr. J.M., and Silva C.L. Efficacy of DNA-hsp65 vaccination for tuberculosis varies with method of DNA introduction in vivo. Vaccine 22 (2003) 49-56
40. Fynan E.F., Webster R.G., Fuller D.H., Haynes J.R., Santoro J.C., and Robinson H.L. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci USA 90 (1993) 11478-11482
41. Chomczynski P., and Sacchi N. Single step methods of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159